Clinical Trials List
2023-01-05 - 2026-09-30
Phase II
Recruiting3
ICD-10D56.0
Alpha thalassemia
ICD-10D56.1
Beta thalassemia
ICD-10D56.2
Delta-beta thalassemia
ICD-10D56.3
Thalassemia minor
ICD-10D56.5
Hemoglobin E-beta thalassemia
ICD-10D56.8
Other thalassemias
ICD-10D56.9
Thalassemia, unspecified
ICD-10D57.40
Sickle-cell thalassemia without crisis
ICD-10D57.411
Sickle-cell thalassemia with acute chest syndrome
ICD-10D57.412
Sickle-cell thalassemia with splenic sequestration
ICD-10D57.419
Sickle-cell thalassemia with crisis, unspecified
ICD-9282.4
Thalassemias
-
Trial Applicant
BRISTOL-MYERS SQUIBB (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
177 participants
